1. Home
  2. MRIN vs WINT Comparison

MRIN vs WINT Comparison

Compare MRIN & WINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRIN
  • WINT
  • Stock Information
  • Founded
  • MRIN 2006
  • WINT 1992
  • Country
  • MRIN United States
  • WINT United States
  • Employees
  • MRIN N/A
  • WINT N/A
  • Industry
  • MRIN EDP Services
  • WINT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • MRIN Technology
  • WINT Health Care
  • Exchange
  • MRIN Nasdaq
  • WINT Nasdaq
  • Market Cap
  • MRIN 2.7M
  • WINT 2.2M
  • IPO Year
  • MRIN 2013
  • WINT 1995
  • Fundamental
  • Price
  • MRIN $0.90
  • WINT $0.49
  • Analyst Decision
  • MRIN
  • WINT Hold
  • Analyst Count
  • MRIN 0
  • WINT 1
  • Target Price
  • MRIN N/A
  • WINT $350.00
  • AVG Volume (30 Days)
  • MRIN 6.4M
  • WINT 7.2M
  • Earning Date
  • MRIN 07-31-2025
  • WINT 08-18-2025
  • Dividend Yield
  • MRIN N/A
  • WINT N/A
  • EPS Growth
  • MRIN N/A
  • WINT N/A
  • EPS
  • MRIN N/A
  • WINT N/A
  • Revenue
  • MRIN $16,707,999.00
  • WINT N/A
  • Revenue This Year
  • MRIN N/A
  • WINT N/A
  • Revenue Next Year
  • MRIN N/A
  • WINT N/A
  • P/E Ratio
  • MRIN N/A
  • WINT N/A
  • Revenue Growth
  • MRIN N/A
  • WINT N/A
  • 52 Week Low
  • MRIN $0.41
  • WINT $0.36
  • 52 Week High
  • MRIN $3.39
  • WINT $737.44
  • Technical
  • Relative Strength Index (RSI)
  • MRIN 47.70
  • WINT 35.91
  • Support Level
  • MRIN $0.86
  • WINT $0.52
  • Resistance Level
  • MRIN $1.66
  • WINT $0.64
  • Average True Range (ATR)
  • MRIN 0.25
  • WINT 0.09
  • MACD
  • MRIN -0.01
  • WINT -0.00
  • Stochastic Oscillator
  • MRIN 23.21
  • WINT 14.12

About MRIN Marin Software Incorporated

Marin Software Inc provides a cloud-based digital advertising management solution for search, display, social, and mobile advertising channels to improve financial performance, realize efficiencies and time savings, and improve business decisions. The company's enterprise marketing software platform is offered as an integrated software-as-a-service (SaaS) solution for advertisers and agencies. Its software solution is designed to help its customers measure the effectiveness of their advertising campaigns through its reporting and analytics capabilities; and manage and execute campaigns through its user interface and underlying technology that streamlines and automates functions. All the business activity of the firm is functioned through the geographical regions of The United States.

About WINT Windtree Therapeutics Inc.

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

Share on Social Networks: